➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
AstraZeneca
Moodys
Colorcon
Boehringer Ingelheim

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

SULFAMETHOXAZOLE AND TRIMETHOPRIM Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Sulfamethoxazole And Trimethoprim, and when can generic versions of Sulfamethoxazole And Trimethoprim launch?

Sulfamethoxazole And Trimethoprim is a drug marketed by Abraxis Pharm, Bedford, Hospira, Mylan Labs Ltd, Somerset, Teva Pharms Usa, Watson Labs, West-ward Pharms Int, Ani Pharms Inc, Aurobindo Pharma, Hi Tech Pharma, Lannett Co Inc, Teva, Amneal Pharms Ny, Chartwell Molecules, Fosun Pharma, Glenmark Generics, Heather, Interpharm, Martec Usa Llc, Mutual Pharm, Pliva, Roxane, Sun Pharm Industries, Usl Pharma, Vista Pharms, Able, and Heritage Pharma. and is included in forty-five NDAs.

The generic ingredient in SULFAMETHOXAZOLE AND TRIMETHOPRIM is phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim. There are eight drug master file entries for this compound. Additional details are available on the phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim profile page.

Summary for SULFAMETHOXAZOLE AND TRIMETHOPRIM
Drug patent expirations by year for SULFAMETHOXAZOLE AND TRIMETHOPRIM
Recent Clinical Trials for SULFAMETHOXAZOLE AND TRIMETHOPRIM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hellenic Institute for the Study of SepsisPhase 2
Atlantic Health SystemPhase 4
Johns Hopkins UniversityEarly Phase 1

See all SULFAMETHOXAZOLE AND TRIMETHOPRIM clinical trials

US Patents and Regulatory Information for SULFAMETHOXAZOLE AND TRIMETHOPRIM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Usl Pharma SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 070203-001 Nov 8, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Martec Usa Llc SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 072408-001 Dec 7, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Fosun Pharma SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH sulfamethoxazole; trimethoprim TABLET;ORAL 018598-004 May 19, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 070002-001 Nov 7, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Heritage Pharma SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH sulfamethoxazole; trimethoprim TABLET;ORAL 070037-001 Jun 2, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
AstraZeneca
Moodys
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.